Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS)

NCT00067808 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndrome
Chronic Myelomonocytic Leukemia

Interventions

DRUG: Decitabine
DRUG: Decitabine
DRUG: Decitabine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]